Aidea Pharma(SH:688488) Zheng Quan Zhi Xing·2025-05-20 12:17Group 1 - The core opinion of the legal opinion letter is that the procedures for convening and holding the annual general meeting of Jiangsu Aidi Pharmaceutical Co., Ltd. comply with relevant laws and regulations [1][4] - The meeting was convened by the board of directors, with the notice published on April 30, 2025, and the meeting held on May 20, 2025 [1][2] - The meeting combined on-site voting and online voting, with the online voting platform provided by the Shanghai Stock Exchange [2][3] Group 2 - A total of 5 shareholders and their proxies attended the meeting in person, holding 191,799,046 shares, which is 45.5815% of the total share capital [3] - Additionally, 71 shareholders participated in online voting, holding 12,725,830 shares, which is 3.0243% of the total share capital [3] - The qualifications of the attendees and the convenor were verified and deemed valid [4] Group 3 - The voting process was conducted by registered voting, and the resolutions were passed in accordance with the meeting agenda [4] - The meeting's voting procedures and results were confirmed to be legal and valid, adhering to the relevant regulations [4] - The legal opinion concludes that the resolutions formed during the meeting are legitimate and effective [4]